How Assistance Works

Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience

  • Coverage Verification Code

    1. Check Your Coverage/Benefits Verification

    Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

  • Transfer Prescription to AmeriPharma - Image

    2. Transfer Prescription to AmeriPharma®

    We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

  • Icon - Eligard copay assistance process

    3. Prior Authorization

    Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

  • Eligard Copay Financial Assistance Icon

    4. Copay Assistance & Financial Aid

    We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma® Specialty Care has secured $55 million in financial assistance for our patients.

  • Nursing Care Logo

    5. Nursing Care Coordination If Needed

    AmeriPharma® puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

  • Delivery Coordination - Image

    6. Delivery Coordination

    Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Tretten Introduction and Uses

Tretten is a brand-name prescription product. It contains catridecacog, a recombinant form of coagulation factor XIII A-subunit. Tretten belongs to a drug class known as coagulation factors or hemostatics.

Tretten is produced using recombinant DNA technology and is not derived from human plasma.

A healthcare provider may prescribe this medication to prevent bleeding in children and adults with congenital factor XIII (FXIII) A-subunit deficiency.

Congenital factor XIII (FXIII) A-subunit deficiency is a rare inherited bleeding disorder. It is estimated to affect 1 in every 1 to 3 million people. In people with this disorder, the blood doesn’t clot properly, leading to a higher risk of [1]:

  • Life-threatening bleeds (most notably, spontaneous bleeding within the brain)
  • Delayed wound healing
  • Recurrent spontaneous abortion in women

Currently, Tretten is the first and only recombinant therapy for people with congenital factor XIII (FXIII) A-subunit deficiency. All other approved treatments are derived from plasma.

This medication shouldn’t be used to treat another similar bleeding disorder called congenital factor XIII B‑subunit deficiency.

Note: Tretten is sold under the brand name NovoThirteen in the EU, Switzerland, and Australia.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg
https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

Tretten Mechanism of Action

Factor XIII A-subunit plays a crucial role in blood clotting. When bleeding occurs, the body forms a mesh of fibrin proteins to create a blood clot. Activated factor XIII helps strengthen and stabilize the clot by linking fibrin strands together.

When you have factor XIII A-subunit deficiency, blood clots become unstable and fragile. As a result, blood clots may break down too easily, increasing the risk of potentially life-threatening bleeding.

Tretten is a lab-created protein that works the same way as the naturally occurring factor XIII-A subunit in the body. Thus, it helps stabilize clots and prevent bleeding.

Important Tretten Warnings and Precautions

Allergic Reactions

This medication may cause allergic reactions. Seek emergency medical care if you experience:

  • Rash
  • Chest tightness
  • Wheezing

You should not use this medication if you have a history of allergic reactions to this product or any product component.

Inhibitor Production

In some cases, your body can make proteins called “inhibitors” that can stop this medication from working as well as it should.

If your immune system makes inhibitors, Tretten may become less effective. Your healthcare provider may test for inhibitors if the medication stops working as expected or your factor XIII activity is lower than expected.

Risk of Blood Clots

If you have a higher risk of blood clots, your healthcare provider will monitor you after administering Tretten. Do not use Tretten together with recombinant factor VIIa, as this combination may increase the risk of blood clots.

How Tretten Copay Assistance Works

AmeriPharma® Specialty Pharmacy alleviates financial burdens for patients and their families

  • Advanced software Icon

    Advanced software locates funding sources to match you with top-dollar foundation programs

  • Copay and Financial Assistance

    One of our copay assistance specialists will assist with the application process

  • Funding Icon

    Automatic updates will be sent to you and your physician on the status of the funding

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/Mask-Group-45-1.jpg

Tretten Dosage

The recommended dose of Tretten for routine bleeding prevention is 35 IU/kg of body weight, administered once every 28 days. Your healthcare provider may monitor factor XIII activity and adjust treatment to maintain trough FXIII activity at or above 10%.

Tretten Administration and Proper Use

  • Your healthcare provider will inject the reconstituted medicine into your vein once monthly.
  • The dose is individualized based on your body weight.
  • You may inject it yourself after receiving instructions from your healthcare provider.
  • Strictly follow the instructions about proper use, dose, and techniques for administration. If you are unclear about anything, ask your healthcare provider for help.
  • Tretten comes as a powder, which must be mixed with sterile water before injection. The sterile water comes in a separate vial.
  • If you need a smaller dose, you may dilute the medicine with 0.9% sodium chloride.
  • Administer Tretten as a slow intravenous injection at a rate not exceeding 1–2 ml per minute, following your healthcare provider’s instructions.
  • Do not mix Tretten with other infusion solutions or administer it as an IV drip.
  • Open the package only when you are ready to administer the medicine.
  • Don’t use expired or damaged medicine.

Tretten Side Effects

Allergic Reactions

Seek emergency medical care if you experience any of the following signs and symptoms after receiving Tretten:

  • Shortness of breath
  • Rash
  • Itching
  • Redness of the skin
  • Fainting
  • Dizziness

 

Blood Clots

Seek emergency medical care if you experience any of the following signs and symptoms after receiving Tretten:

  • Pain, swelling, warmth, redness, or a lump in the legs or arms
  • Chest pain
  • Sudden severe headache
  • Fainting

Call your doctor immediately if you have any unexpected bleeding.

Other side effects can include:

  • Pain in the arms or legs
  • Headache
  • Pain at the injection site
  • Increased D-dimer levels (a laboratory finding related to blood clot formation and breakdown)

 

 

Insurances Accepted

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

  • Medicare logo displayed in the website footer.
  • Medicaid logo
  • Blue Cross Blue Shield Logo

Get Started in Minutes

Fill out your information and one of our specialists will call you ASAP.

How Much Can You Save?

Complete this form to save up to 100%!

HIPAA Compliant